AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.110

0.000

Volume:2.17M

Turnover:4.62M

Market Cap:2.74B

PE:-33.02

High:2.160

Open:2.110

Low:2.100

Close:2.110

52wk High:3.310

52wk Low:1.880

Shares:1.30B

Float Shares:786.49M

Volume Ratio:0.93

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.064

EPS(LYR):-0.064

ROE:-9.86%

ROA:-4.11%

PB:3.34

PE(LYR):-33.02

Loading ...

Overview Company News Filings

ASX Growth Companies With High Insider Ownership September 2026

Simply Wall St.

Australia's Mesoblast Rises on FDA Approval for New Potency Assay for Commercial Ryoncil

Mesoblast - Receives FDA Approval for New Potency Assay for Commercial Ryoncil Product

THOMSON REUTERS

PDI Gold And 2 Australian Founder Led Growth Stocks

Simply Wall St.

Is Mesoblast (ASX:MSB) Cheap Following Its Stronger Full Year Earnings?

Simply Wall St.

ASX Penny Stocks To Watch In September 2026

Simply Wall St.

ASX Growth Companies With High Insider Ownership

Simply Wall St.

High Growth Tech Stocks In Australia Echo IQ And 2 More To Watch

Simply Wall St.

Founder Led Stocks With Long Term Alignment Investors Should Watch

Simply Wall St.

Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically

Simply Wall St.

3 Founder Led Australian Stocks Built For Higher Rates

Simply Wall St.

3 Penny Stocks With Real Revenue And Solid Balance Sheets

Simply Wall St.

Mesoblast (ASX:MSB) Shares Rally Meets Persistent Cash Burn

Simply Wall St.

Cash Flow Stocks Retail Investors May Be Missing In Australia

Simply Wall St.

Alkane Resources Stock Tops Financially Strong Penny Stocks To Watch

Simply Wall St.

Mesoblast FY26 Net Loss Narrows 44% to Us$57.5 Million; Revenue More than Doubled to Us$120.3 Million

Mesoblast Reports Substantial Revenue Growth to Us$120m

THOMSON REUTERS

Founder Led Stocks Retail Investors Are Tracking For Long Term Alignment

Simply Wall St.

Mesoblast Limited - There Can be no Assurance That We Will Ever Achieve or Maintain Profitability

THOMSON REUTERS

Mesoblast Limited - Anticipate That We May Continue to Incur Significant Losses for Foreseeable Future

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/MSB.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.11,"timestamp":1790748720000,"preClose":2.11,"halted":0,"volume":2171589,"delay":0,"changeRate":0,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.06390594886660497,"marketStatus":"Not Yet Opened","change":0,"latestTime":"09-30 16:12:00 AEST","open":2.11,"high":2.16,"low":2.1,"amount":4617668,"amplitude":0.028436,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.06390594886660497,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.11,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":0.9285899745164856,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":2.11,"auctionPrice":2.11,"auctionVolume":13574,"auctionTime":1790811951640,"referenceTime":1790764203089,"auction":1,"marketStatus":"盘前竞价","timestamp":1790811951640}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-4.11%","roe":"-9.86%","lyrEps":-0.063906,"volumeRatio":0.9285899745164856,"shares":1296862776,"dividePrice":0,"high":2.16,"amplitude":0.028436,"preClose":2.11,"low":2.1,"week52Low":1.88,"pbRate":"3.34","psRate":"15.81","week52High":3.31,"institutionHeld":0,"latestPrice":2.11,"eps":-0.06390594886660497,"divideRate":0,"volume":2171589,"delay":0,"ttmEps":-0.06390594886660497,"open":2.11,"prevYearClose":2.72,"prevWeekClose":2.16,"prevMonthClose":2.11,"prevQuarterClose":2.11,"fiveDayClose":2.18,"twentyDayClose":2.37,"sixtyDayClose":2.02,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672411738","title":"ASX Growth Companies With High Insider Ownership September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672411738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672411738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:08","pubTimestamp":1790795293,"startTime":"0","endTime":"0","summary":"In the wake of the recent RBA rate increase, the Australian market is experiencing a period of volatility, with mixed signals from global markets and fluctuating commodity prices adding to investor uncertainty. Amidst these conditions, growth companies with high insider ownership can offer unique insights into potential resilience and alignment between management and shareholder interests, making them noteworthy in today's economic climate.","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-september-2-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-september-2-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELS.AU","GYG.AU","IQ","GEAR.AU","STW.AU","OZR.AU","OZF.AU","XKO.AU","IIGF.AU","XAO.AU","BK4531","BK4526","BK7023","BEAR.AU","EIGA.AU","BK7508","EMR.AU","BK4108","SPL.AU","BK7084","EIQ.AU","VAS.AU","FRS.AU","AR1.AU","IISV.AU","AV1.AU","IMLC.AU","BK7104","BK7093","SKS.AU","BK4552","BK7501","XJO.AU","PDI.AU","BK7095","BK7017","MSB.AU","VAP.AU","BK7137","IOZ.AU","SLF.AU","WZR.AU","DACE.AU","AEM.AU","QRE.AU","ZYAU.AU","BBOZ.AU","GIVE.AU","E200.AU","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669379574","title":"Australia's Mesoblast Rises on FDA Approval for New Potency Assay for Commercial Ryoncil","url":"https://stock-news.laohu8.com/highlight/detail?id=2669379574","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669379574?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:38","pubTimestamp":1790210283,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mesoblast rises on FDA approval for new potency assay for commercial Ryoncil** Shares of MesoblastMSB.AXrise as much as 5.1% to A$2.29, their biggest intraday pct gain since August 28","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G01P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432383","title":"Mesoblast - Receives FDA Approval for New Potency Assay for Commercial Ryoncil Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669432383?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:52","pubTimestamp":1790207540,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUEBVRFV4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MESO","BK7067","BK4139","BK7501","MSB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668888661","title":"PDI Gold And 2 Australian Founder Led Growth Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2668888661","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668888661?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:29","pubTimestamp":1789748965,"startTime":"0","endTime":"0","summary":"Central banks are lifting interest rates again, and history shows that higher borrowing costs often hit fast growers hardest. Australian companies where founders and executives hold big stakes can sometimes weather that pressure better, because management feels every share price move in their own net worth. This article looks at three fast growing, high insider ownership stocks from our screener and explains why each might deserve a spot on your watchlist.\nThe three stocks below are just a...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/pdi-gold-and-2-australian-founder-led-growth-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/pdi-gold-and-2-australian-founder-led-growth-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAR.AU","SLF.AU","IISV.AU","XJO.AU","BK7104","OZF.AU","TLX.AU","BBOZ.AU","QFN.AU","BK7067","BK4139","EIGA.AU","BK7501","IOZ.AU","ZYAU.AU","E200.AU","PDI","GEAR.AU","VAS.AU","VAP.AU","MSB.AU","USD","STW.AU","IIGF.AU","USD.AU","TLX","XAO.AU","GIVE.AU","XKO.AU","QRE.AU","DACE.AU","IMLC.AU","BK7508","PDI.AU","OZR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664236798","title":"Is Mesoblast (ASX:MSB) Cheap Following Its Stronger Full Year Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664236798","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664236798?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:27","pubTimestamp":1788402454,"startTime":"0","endTime":"0","summary":"What Mesoblast’s latest earnings tell you about the business\nMesoblast (ASX:MSB) has attracted fresh attention after reporting full year 2026 results on 26 August, with revenue of US$120.25 million and a reduced net loss of US$57.5 million compared with the prior year.\nFor investors watching Mesoblast stock, the combination of higher reported revenue and a smaller loss per share, both basic and diluted, puts the company’s regenerative medicine pipeline and funding needs back in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-cheap-following-its-stronger-full-year-e","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-cheap-following-its-stronger-full-year-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664601823","title":"ASX Penny Stocks To Watch In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664601823","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664601823?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:04","pubTimestamp":1788401097,"startTime":"0","endTime":"0","summary":"The Australian stock market is poised for a positive start today, with the ASX expected to open higher following a rebound on Wall Street. Amidst this backdrop of fluctuating indices and evolving economic trends, investors are increasingly looking at opportunities in less conventional areas. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still present valuable opportunities when they possess strong financial foundations and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-penny-stocks-to-watch-in-september-2026-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7016","KSC.AU","BVS.AU","BK7501","BK7503","BK7058","MSB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837618","title":"ASX Growth Companies With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837618","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837618?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:08","pubTimestamp":1788203298,"startTime":"0","endTime":"0","summary":"As the S&P/ASX 200 reflects global market jitters with a predicted dip following Wall Street's inflation concerns, investors are keenly watching for opportunities in growth companies that demonstrate resilience and potential. In this environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those who know the company best, aligning management interests with shareholder value.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-16","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/asx-growth-companies-with-high-insider-ownership-16","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7110","SLF.AU","DACE.AU","BK4526","IQ","BK7093","QRE.AU","AWJ.AU","E200.AU","VAS.AU","BK7104","BK4531","IIGF.AU","AR1.AU","BK4108","TTT.AU","GEAR.AU","OZR.AU","XAO.AU","XKO.AU","BEAR.AU","PNI.AU","XJO.AU","EIQ.AU","BK7508","AEM.AU","BK7067","OZF.AU","BK7023","PDI.AU","EIGA.AU","BK7062","BK7501","BK7095","VAP.AU","WZR.AU","IMLC.AU","SKS.AU","STW.AU","BK4505","GIVE.AU","MSB.AU","IOZ.AU","IISV.AU","ZYAU.AU","QFN.AU","BK7017","FRS.AU","SPL.AU","BBOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883108","title":"High Growth Tech Stocks In Australia Echo IQ And 2 More To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883108","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883108?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:06","pubTimestamp":1788203178,"startTime":"0","endTime":"0","summary":"As the Australian market grapples with inflation concerns mirroring Wall Street's recent performance, the S&P/ASX 200 is expected to open lower despite a positive close last week. In this environment of economic uncertainty and fluctuating indices, high-growth tech stocks like Echo IQ are gaining attention for their potential to thrive through innovation and adaptability, making them compelling options for investors seeking growth opportunities in a volatile market landscape.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/high-growth-tech-stocks-in-australia-echo-iq-and-2-more-to-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/high-growth-tech-stocks-in-australia-echo-iq-and-2-more-to-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4108","OZR.AU","OZF.AU","IOZ.AU","BBOZ.AU","E200.AU","USD","GIVE.AU","ZYAU.AU","STW.AU","BK7067","EUFX","IISV.AU","SLF.AU","IQ","QFN.AU","BK4505","MSB.AU","BK7084","VAP.AU","BK4531","IMLC.AU","BK7501","BK4526","EIGA.AU","BK7508","XJO.AU","DACE.AU","GEAR.AU","BK4552","IIGF.AU","QRE.AU","BK7016","XAO.AU","CROC","VAS.AU","EIQ.AU","BEAR.AU","ELS.AU","XKO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002013","title":"Founder Led Stocks With Long Term Alignment Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002013","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002013?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:22","pubTimestamp":1788189735,"startTime":"0","endTime":"0","summary":"With central banks signaling that interest rates may stay higher for longer, investors face a tougher backdrop for companies that rely on cheap capital and short term momentum. Founder led businesses often take a different path. Leaders with significant skin in the game tend to think in decades, not quarters. This article highlights 3 founder led stocks from our screener that show how this ownership mindset can shape long term opportunity.\nThe three founder led stocks in this article are only...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/founder-led-stocks-with-long-term-alignment-investors-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/founder-led-stocks-with-long-term-alignment-investors-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7042","ISBC","BK7067","BK7094","PME.AU","MAQ.AU","BK7508","BK7046","BK4211","BK7511","BK7501","BK7043","MQG.AU","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607448","title":"Analysts Just Shaved Their Mesoblast Limited (ASX:MSB) Forecasts Dramatically","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607448","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663607448?lang=en_us&edition=fundamental","pubTime":"2026-08-31 12:37","pubTimestamp":1788151054,"startTime":"0","endTime":"0","summary":"One thing we could say about the analysts on Mesoblast Limited ( ASX:MSB ) - they aren't optimistic, having just made a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/analysts-just-shaved-their-mesoblast-limited-asxmsb-forecast","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7508","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663721010","title":"3 Founder Led Australian Stocks Built For Higher Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2663721010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663721010?lang=en_us&edition=fundamental","pubTime":"2026-08-30 01:17","pubTimestamp":1788023852,"startTime":"0","endTime":"0","summary":"Central banks are hinting that interest rates could stay higher for longer as inflation pressures persist. That kind of backdrop tends to reward leaders who think and act like long term owners. Founder led companies often fit that profile, with executives whose own wealth is tied to what you care about: long term equity value. This article highlights 3 founder led stocks from our screener that show how that mindset looks in practice.\nThe three founder led stocks in this article are just a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/3-founder-led-australian-stocks-built-for-higher-rates","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/3-founder-led-australian-stocks-built-for-higher-rates","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IOZ.AU","BK7046","XKO.AU","BK7042","IIGF.AU","XAO.AU","BK7094","E200.AU","IMLC.AU","ZYAU.AU","BK7043","BBOZ.AU","GIVE.AU","XJO.AU","DACE.AU","BK7501","VAS.AU","BEAR.AU","MQG.AU","STW.AU","VAP.AU","QRE.AU","BK7511","QFN.AU","EIGA.AU","BK7067","MAQ.AU","PME.AU","SLF.AU","MSB.AU","GEAR.AU","OZF.AU","BK7508","OZR.AU","IISV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663192110","title":"3 Penny Stocks With Real Revenue And Solid Balance Sheets","url":"https://stock-news.laohu8.com/highlight/detail?id=2663192110","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663192110?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:29","pubTimestamp":1787952565,"startTime":"0","endTime":"0","summary":"Global inflation readings in Europe are keeping interest rate expectations elevated, which keeps borrowing costs in focus for smaller companies. That is where the Financially Fit Penny Stocks screener becomes interesting. It filters for low priced stocks that still show solid financial health, so investors are not just chasing cheap tickers. This article highlights three stocks from the screener that may be worth considering for your watchlist.\nThe three stocks highlighted below are just a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/3-penny-stocks-with-real-revenue-and-solid-balance-sheets","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/3-penny-stocks-with-real-revenue-and-solid-balance-sheets","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK4585","BK7104","BK7501","SIG.AU","LABU","MSB.AU","ALK.AU","BK7506","XBI","BK7508","BK4588","BK7103","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662696084","title":"Mesoblast (ASX:MSB) Shares Rally Meets Persistent Cash Burn","url":"https://stock-news.laohu8.com/highlight/detail?id=2662696084","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662696084?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:35","pubTimestamp":1787834131,"startTime":"0","endTime":"0","summary":"The market has Mesoblast trading around A$2.41 after a choppy week that left the stock down about 4% over seven days but still up double digits over one and three months. That price action suggests investors are torn between excitement over the story and concern about the cost of pursuing that growth.\nThe main takeaway from this earnings release is straightforward. Mesoblast reported its first full commercial year of RYONCIL revenue at US$115 million, yet still posted a net loss of US$57.5...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-shares-rally-meets-persistent-cash-burn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-shares-rally-meets-persistent-cash-burn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771276","title":"Cash Flow Stocks Retail Investors May Be Missing In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771276","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771276?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:25","pubTimestamp":1787808304,"startTime":"0","endTime":"0","summary":"Central banks in Europe are still signalling possible rate hikes to contain inflation. That keeps pressure on broad equity valuations and makes reliable cash generation more valuable. When investors worry about the path of rates, stocks with strong cash flow support and discounts to estimated fair value can look appealing. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that fit that profile.\nThe stocks covered below are just a small sample, and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/cash-flow-stocks-retail-investors-may-be-missing-in-australi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/cash-flow-stocks-retail-investors-may-be-missing-in-australi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QFN.AU","BK7503","DACE.AU","ZYAU.AU","BBOZ.AU","IIGF.AU","GIVE.AU","BEAR.AU","XAO.AU","TLX","STW.AU","BK4585","BK7067","TLX.AU","IMLC.AU","QRE.AU","SPHQ","GEAR.AU","E200.AU","IISV.AU","XKO.AU","XJO.AU","BK4211","SLF.AU","VAS.AU","BK7508","IOZ.AU","BK4139","EIGA.AU","BK7016","ISBC","WTC.AU","OZF.AU","BK4588","BK7501","VAP.AU","OZR.AU","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662272723","title":"Alkane Resources Stock Tops Financially Strong Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662272723","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662272723?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:32","pubTimestamp":1787797966,"startTime":"0","endTime":"0","summary":"Oil price declines are easing some inflation worries, which keeps central banks guessing and investors hunting for pockets of potential growth at a discount. That is where the Financially Fit Penny Stocks screener can help. It filters for lower priced stocks with stronger balance sheets than many early-stage peers. This article highlights three of the most interesting candidates and what to watch before you consider them.\nThe three stocks in this article are just a small sample, and the full...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-tops-financially-strong-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-tops-financially-strong-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CEF","OUNZ","BTGD","IAUI","UGL","GOLY","BGLD","GLD","GDXW","XLV","XME","GDXD","FGDL","GBUG","GLDM","LABU","GLL","UYM","SIG.AU","GDX","02840","GLTR","YGLD","GDXU","RING","DZZ","JNUG","JDST","USG","DGP","SHNY","MSB.AU","DBC","DULL","BEGS","DUST","PICK","IAU","SGOL","XBI","GDXJ","SGDM","BAR","GDXY","ALK.AU","IAUM","PPI","GOAU","PHYS","AAAU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700725","title":"Mesoblast FY26 Net Loss Narrows 44% to Us$57.5 Million; Revenue More than Doubled to Us$120.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700725","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662700725?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:32","pubTimestamp":1787790751,"startTime":"0","endTime":"0","summary":"Mesoblast FY26 net loss narrows 44% to US$57.5 million; revenue more than doubled to US$120.3 millionMesoblast posted FY2026 revenue of US$120.3 million, up from US$17.2 million a year earlier, on Ryo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLKTZvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK4585","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","NDAQ","SG9999014005.SGD","LU2210150020.SGD","IE00BQXX3D17.EUR","BK7501","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BCDF","IE00BN0W2T93.GBP","BK4588","BK4112","SG9999014013.SGD","MSB.AU","BK7067","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662272574","title":"Mesoblast Reports Substantial Revenue Growth to Us$120m","url":"https://stock-news.laohu8.com/highlight/detail?id=2662272574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662272574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:32","pubTimestamp":1787790727,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUABRVVHM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662727409","title":"Founder Led Stocks Retail Investors Are Tracking For Long Term Alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662727409","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662727409?lang=en_us&edition=fundamental","pubTime":"2026-08-27 08:29","pubTimestamp":1787790593,"startTime":"0","endTime":"0","summary":"Central banks are still debating how far to push interest rates, which keeps a spotlight on companies that do not rely on cheap capital to grow. Founder led businesses often fit that profile because leaders usually think in decades, not quarters. That long term mindset can appeal to investors who want skin in the game. This article highlights three founder led stocks from the screener that show how that approach looks in practice.\nThe three founder led stocks below are just a starting sample,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-retail-investors-are-tracking-for-long-te","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-retail-investors-are-tracking-for-long-te","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BK4588","BK7501","MAQ.AU","BK7046","BK4585","SPHQ","BK7508","BK7067","FLT.AU","ISBC","BK7043","MQG.AU","MSB.AU","BK7070","BK7511","BK7042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740244","title":"Mesoblast Limited - There Can be no Assurance That We Will Ever Achieve or Maintain Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740244?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:25","pubTimestamp":1787783102,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0OW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7508","BK7067","BK4139","BK7501","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740240","title":"Mesoblast Limited - Anticipate That We May Continue to Incur Significant Losses for Foreseeable Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740240?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:25","pubTimestamp":1787783102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0OW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","MSB.AU","BK4139","BK7067","BK7508","MESO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":174,"code":"91000000","status":"200"}]}}